Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Tumor Ablation Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The tumor ablation market has experienced swift expansion in recent years. This market is projected to expand from $1.62 billion in 2025 to $1.81 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.8%. Historically, this growth stems from factors such as the increasing incidence of solid tumors, wider adoption of minimally invasive cancer treatments, the expansion of oncology care centers, the availability of advanced imaging guidance, and enhanced clinical outcomes of ablation therapies.
The tumor ablation market is anticipated to experience substantial growth in the upcoming years, with its size expected to reach $2.69 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 10.4%.
This projected growth throughout the forecast period is driven by several factors, including an escalating demand for targeted cancer therapies, increased investments in precision oncology solutions, the expansion of outpatient facilities for cancer treatment, the integration of AI-based treatment planning, and an increasing focus on patient-centric cancer care.
Significant trends identified for the forecast period include a growing adoption of minimally invasive ablation procedures, the rising utilization of image-guided ablation technologies, a developing preference for thermal ablation techniques, the proliferation of outpatient settings for tumor treatment, and an enhanced emphasis on precision oncology.
Get A Free Sample Report With In-Depth Market Insights:
Tumor Ablation Market Growth Backed By Core Demand Fundamentals
The expanding adoption of minimally invasive procedures is projected to propel the growth of the tumor ablation market in the future. These interventions, including robot-assisted surgeries, are surgical techniques that utilize small or no incisions, aiming to reduce recovery time, minimize complications, and alleviate postoperative pain. This progression is driven by increasing patient preference for quicker recovery, advancements in surgical robotics, and enhanced accuracy in imaging-guided treatments. Tumor ablation technologies, such as radiofrequency, microwave, and cryoablation, align with this trend by enabling the precise destruction of cancerous tissue while preserving surrounding healthy structures. For instance, in June 2024, data from the American Society of Plastic Surgeons, a US-based non-profit organization, indicated that minimally invasive procedures grew by 7% in 2023, exceeding the growth rate of surgical procedures by 2%. Hand surgeries for conditions like carpal tunnel, arthritis, and trigger finger collectively amounted to 207,887 procedures, representing a 2% rise from 2022. Consequently, the increasing application of minimally invasive procedures is driving the expansion of the tumor ablation market.
Tumor Ablation Market Segment Landscape And Growth Outlook
The tumor ablation market covered in this report is segmented –
1) By Type: Thermal Ablation, Chemical Ablation
2) By Types Of Treatment: Percutaneous, Laparoscopic, Surgical
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Cancer
4) By End Users: Hospitals, Oncology Centers, Other End Users
Subsegments:
1) By Thermal Ablation: Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)
2) By Chemical Ablation: Ethanol Ablation, Acetic Acid Ablation, Transarterial Chemoembolization
Tumor Ablation Market Growth Trends Reshaping The Competitive Landscape
Leading companies in the tumor ablation market are developing advanced products, such as bone tumor ablation systems, to improve treatment effectiveness, enhance patient outcomes, and expand the variety of tumors that can be addressed. A bone tumor ablation system is a specialized medical instrument utilized for treating bone tumors through less invasive procedures. For instance, in March 2024, Medtronic plc, an Ireland-based medical device company, obtained U.S. Food and Drug Administration (FDA) 510(k) clearance for its OsteoCool 2.0 bone tumor ablation system. This improved system is intended for treating painful bone metastases and benign bone tumors, including osteoi osteoma. The OsteoCool 2.0 permits the simultaneous operation of four internally cooled probes, allowing medical professionals to ablate two vertebral bodies concurrently or generate broader ablation zones in extra-spinal applications. It provides 20W per channel, which is more than double the power of the Stryker OptaBlate bone tumor ablation system.
Tumor Ablation Market Top Companies Driving Competitive Growth
Major companies operating in the tumor ablation market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Varian Medical Systems Inc., Merit Medical Systems Inc., Accuray Incorporated, AngioDynamics Inc., EDAP TMS S.A., NeuWave Medical Inc., Mirabilis Medical Inc., STARMed Co. Ltd., Profound Medical Corp., RF Medical Co. Ltd., IceCure Medical Ltd., MedWaves Inc., Chongqing Haifu Medical Technology Co. Ltd., Hologic Inc., Johnson & Johnson MedTech
View The Full Tumor Ablation Market Report:
Tumor Ablation Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the tumor ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
